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Abstract
Background: The nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an important
coordinator of glucose homeostasis. We report, for the first time, a unique differential regulation of its expression by the
nutritional status in the mouse hypothalamus compared to peripheral tissues.
Methodology/Principal Findings: Using hyperinsulinemic-euglycemic clamps and insulinopenic mice, we show that insulin
upregulates its expression in the hypothalamus. Immunofluorescence studies demonstrate that COUP-TFII gene expression
is restricted to a subpopulation of ventromedial hypothalamic neurons expressing the melanocortin receptor. In GT1-7
hypothalamic cells, the MC4-R agonist MTII leads to a dose dependant increase of COUP-TFII gene expression secondarily to
a local increase in cAMP concentrations. Transfection experiments, using a COUP-TFII promoter containing a functional
cAMP responsive element, suggest a direct transcriptional activation by cAMP. Finally, we show that the fed state or
intracerebroventricular injections of MTII in mice induce an increased hypothalamic COUP-TFII expression associated with a
decreased hepatic and pancreatic COUP-TFII expression.
Conclusions/Significance: These observations strongly suggest that hypothalamic COUP-TFII gene expression could be a
central integrator of insulin and melanocortin signaling pathway within the ventromedial hypothalamus. COUP-TFII could
play a crucial role in brain integration of circulating signal of hunger and satiety involved in energy balance regulation.
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Introduction
The hypothalamus receives information from circulating nutri-
ents and hormones and integration of these signals by appropriate
neurocircuitry will in turn translate into adaptive metabolic and
behavioralresponsesinorder to sustain energybalance. Food intake
modulation, insulin secretion and peripheral glucose metabolism
together with endocrine regulation are part of this integrated
response. Any disturbance of this mechanism leads to metabolic
diseases such as obesity and diabetes [1,2].
Nuclear receptors are part of a family of ligand-activated
transcription factor such as PPARs, LXRs, RXR, involved in the
regulation of many key metabolic functions both at the central and
peripheral level. Among these transcription factors, our team has
focused its attention on the Chicken Ovalbumin Upstream
Promoter-Transcription Factor II (COUP-TFII also named
NR2F2). COUP-TFII is an orphan member of the steroid/
thyroid hormone receptor superfamily with no identified physio-
logical ligand. It binds DNA by a zinc finger motif on a variety of
hormone responsive elements that contain direct or inverted
imperfect AGGTCA repeats with various spacings [3]. COUP-
TFII is involved in the control of development, cellular
differentiation, growth and metabolism [4,5,6]. In terms of
metabolic control, we and others showed its functional role in
respect to genetic programs associated with insulin biosynthesis
and secretion in pancreatic beta cells [7,8], in the regulation of
lipid utilization/cholesterol homeostasis in skeletal muscle cells [9]
and in white adipose tissue development and energy metabolism
[10]. The fact that heterozygous COUP-TFII gene inactivation
mouse models, i.e conditional beta cells [8] or complete
invalidation [10] (50% decrease in COUP-TFII expression)
displayed a strong phenotype suggests that any small variations
of COUP-TFII expression does lead to a disturbed physiology.
Interestingly, its expression is modulated by the nutritional
status in several tissues. We previously reported that COUP-TFII
expression was reduced in the pancreas and liver of mice refed
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13464onto with a carbohydrate rich diet [7]. In fact, COUP-TFII gene
expression is decreased by secreted insulin in response to glucose
in pancreatic beta cells and by insulin and glucose in hepatocytes
[7]. In situ hybridization data showed that COUP-TFII mRNA
was also expressed in the hypothalamus [11,12].
As an actor of glucose homeostasis, whose expression is
modulated by the nutritional status in several tissues and as it is
expressed in the hypothalamus whose function is central to energy
homeostasis, it was of interest to decipher the regulation of COUP-
TFII expression by the nutritional status in the hypothalamus.
In this paper, we report 1) a differential regulation of COUP-
TFII mRNA levels by the nutritional status with an induction of
its expression in the hypothalamus in the fed state 2) COUP-TFII
protein expression in a subpopulation of ventromedial hypotha-
lamic neurons 3) COUP-TFII expression in the hypothalamus
and in a hypothalamic cell line being controlled by the
melanocortin pathway leading t oad i r e c tC O U P - T F I It r a n -
scriptional activation.
Results
Hypothalamic COUP-TFII expression is induced by the
fed state in adult mice
Previous studies from our lab and from others had observed an
expression of COUP-TFII mRNA in embryonic and adult
hypothalamus [12,13,14]. From our previous studies on COUP-
TFII mRNA regulation in liver and pancreas, we looked at the
regulation of COUP-TFII mRNA levels in the hypothalamus of
C57bl/6J adultmice accordingtotheirnutritionalstatus.Mice were
subjected to a 24 hours fast and compared with mice refed a regular
chow diet for 6 hours, which causes a major switch leading to
elevated plasma glucose (from 102610.2 mg/dl at the fasted state
to 16569.5 mg/dl in the fed mice) and plasma insulin levels (from
0.660.2 at the fasted state to 1.960.3 in the fed mice). In the
hypothalamus, the fed state is characterized by increased proopio-
melanocortin (POMC) and decreased agouti related protein (AgRP)
mRNA and neuropeptide Y (NPY) mRNA contents [15,16,17], as
observed in our mice (figure 1A). Refed mice displayed significantly
higher COUP-TFII mRNA levels (48%) in the hypothalamus than
the fasted mice (figure 1B). In these experiments, we analyzed also
COUP-TFII protein expression. We observed a significantly higher
expression in the hypothalamus of the fed mice than in the
hypothalamus of the fasted mice with the characteristic migration
profile with 2 bands, the minor higher molecular weight band
corresponding to a post translational modified COUP-TFII protein
[18]. In these experiments, the ratio of the two bands was modified
in a similar way between the fasted and the fed state (figure 1C).
Taken altogether, these results suggested that the changes in
hypothalamic COUP-TFII expression could be centrally regulated
by signals of energy supplies such as blood glucose or plasma insulin
levels. To confirm this hypothesis, we investigated the effects of
glucose and/or insulin in the control of hypothalamic COUP-TFII
mRNA levels.
As insulin and glycemia are so tightly linked, in order to
distinguish between the relative implication of glucose or insulin
on hypothalamic COUP-TFII regulation, we used the euglyce-
mic/hyperinsulinemic (eGHI) clamp technique to impose high
circulating insulin while maintaining euglycemia with an intra-
jugular glucose infusion (figure 2A). First, we analyzed POMC,
AgRP and NPY mRNAs levels in these clamped mice (figure 2B)
and observed a significant 3 fold increase in POMC mRNA levels
and a 2.3 and 1.6 fold decrease respectively in AgRP and NPY
mRNA levels in the eGHI mice compared to the control mice
(figure 2B). In these experiments, COUP-TFII mRNA levels were
significantly increased by a 2.2 fold in the eGHI clamped mice
compared to the control mice (figure 2C). Thus, insulin per se was
able to induce COUP-TFII mRNA levels in the hypothalamus
independently of glucose.
Conversely, we analyzed COUP-TFII mRNA levels in the
hypothalamus of insulinopenic mice. We generated type 1 diabetic
mouse models using streptozotocin injections. The control mice
received citrate buffer injections (the streptozotocin vehicle). Once
the hyperglycemia (470650 mg/dl) was stable (i.e. 8 days) in the
STZ mice, the hypothalamic gene expression was analyzed
(figure 3A). In parallel, a subgroup of STZ treated mice received
an insulin injection (1.5 U/kg) two hours prior to the sacrifice. At
the time of sacrifice, the glycemia of these insulin injected STZ
mice had dropped down to 120627 mg/dl (figure 3A). In the STZ
treated mice, POMC mRNA levels were drastically decreased by a
8 fold, whereas in the STZ subgroup receiving the insulin
injection, POMC mRNA levels were reinduced by a 3.4 fold.
Conversely, hypothalamic AgRP and NPY mRNA levels were
respectively 3 and 10 fold higher in STZ treated mice than in the
control citrate mice, however the insulin injection rapidly
repressed their expressions (figure 3B). In these experiments,
COUP-TFII mRNA levels dropped dramatically (80%) in
insulinopenic mice compared to their control mate whereas
exogenous insulin injection induced a rapid and significant
increase in COUP-TFII mRNA levels within 2 hours compared
to the STZ mice (figure 3B). Taken all together, these results
showed that insulin is able to induce a rapid increase in
hypothalamus COUP-TFII gene expression. These results are
quite intriguing since our previous data had clearly demonstrated
that COUP-TFII gene expression was decreased by insulin in
hepatocytes and in pancreatic b cells and decreased in liver and
pancreas of fed mice [7]. Therefore, we questioned how the fed
state could have such an opposite effect on COUP-TFII mRNA
expression in the hypothalamus compared to the liver and the
pancreas.
COUP-TFII expression is restricted to a subpopulation of
VMH neurons
The hypothalamus is a complex structure consisting of
anatomically distinct nuclei that work in a coordinate fashion to
regulate vegetative functions [19]. In order to decipher the
mechanisms by which insulin is able to stimulate hypothalamic
COUP-TFII gene expression, we needed to identify precisely the
nuclei expressing this transcription factor. Therefore, we did a
study of COUP-TFII protein expression profile by immunohisto-
chemistry on cryostat sections of C57bl/6J fed mice brains
(figure 4). After a Kluver Barrera staining, the hypothalamic nuclei
were identified using a mouse brain atlas as well as morphological
brain markers (figure 4A). Throughout all hypothalamic sections,
we detected the COUP-TFII protein only in the ventromedial
nuclei (VMH) with the very characteristic perinuclear profile
(figure 4B–H). This protein expression profile is reminiscent of the
COUP-TFII mRNA expression profiles observed by in situ
hybridization studies (Allen Brain Atlas). These data confirmed
the highly restricted expression of the protein. The secondary
antibody specificity was confirmed on cryostat sections done
without primary antibody incubation (figure 4C). Similar exper-
iments using a primary monoclonal antibody directed against the
COUP-TFI homologue, a closely related protein, were done and
no expression was observed in the VMH while it was clearly
expressed in cortical subpopulations on the same cryostat section,
as previously described [20] (figure 4I–J).
The VMH remains poorly defined in terms of cellular and
molecular genetic markers as tool to identify cell subgroups.
Neuronal COUP-TFII Regulation
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identification of some specific markers of the different cell
subpopulations [12]. Among them, COUP-TFII had one of the
highest levels of expression [12]. In order to delineate if COUP-
TFII was more specifically expressed in neurons or astrocytes, we
undertook a co-localization study with an astrocyte specific
marker, the Glial Fibrilary Acidic Protein (GFAP). No overlapping
expression with COUP-TFII protein was observed, suggesting that
COUP-TFII was not expressed in astrocytes (data not shown).
Among the identified VMH markers, the nuclear receptor
steroidogenic factor 1 (SF1) is expressed in a large subpopulation
of neurons involved in the central control of glucose homeostasis
[21,22]. We addressed the possible overlap between COUP-TFII
and SF1 expression within the VMH with a double immuno-
Figure 1. In vivo COUP-TFII expression in the hypothalamus during the fasting refeeding cycle. C57BL/6J mice are either fasted for 24 h
(%) or fasted 24 h and refed on a regular diet (&). (A) RT-qPCR analysis of POMC (upper left panel), AgRP mRNA levels (upper right panel), NPY mRNA
(lower left panel), Neuro D mRNA levels (lower right panel) (B) RT-qPCR analysis of COUP-TFII mRNA levels. Data are expressed as mean 6 SEM. (n=5
mice/group) *P#0.05; **P#0.01 when compared to fasted conditions. (C) Autoradiogram of a western blot analysis of COUP-TFII protein expression
in the hypothalamus. Upper panel: COUP-TFII protein, lower panel: b actin protein.
doi:10.1371/journal.pone.0013464.g001
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the SF1 protein were observed in the VMH (figure 5A, red
fluorescence). Interestingly, not all VMH cells were expressing
COUP-TFII (figure 5B, green fluorescence). By overlapping the
two fluorescences, we observed that all the COUP-TFII positive
neurons were also expressing the SF1 protein (overlapping green
and red fluorescence) (figure 5E, yellow fluorescence). However,
some SF1 cells were not expressing COUP-TFII (white arrows),
suggesting that we had at least two distinct cellular subpopulations
of SF1 neurons within the VMH, the COUP-TFII positive and the
Figure 2. COUP-TFII mRNA levels in the hypothalamus of eGHI clamped mice. (A) Blood glucose and plasma insulin (B-C) RT-qPCR analysis of mRNA
levels in the hypothalamus of eGHI clamped mice. (B) Left panel: POMC mRNA levels; middle panel: AgRP mRNA levels; right panel: NPY mRNA levels (C) COUP-
TFII mRNA levels. Saline control mice (%), eGHI (&) Data are expressed as mean 6S.E.M. (n=6 mice/group). **P#0.01 when compared to saline control mice.
doi:10.1371/journal.pone.0013464.g002
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PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13464Figure 3. COUP-TFII mRNA levels in the hypothalamus of STZ treated mice. (A) Glycemia (B) RT-qPCR analysis of mRNA levels. Upper left
panel: POMC mRNA levels; upper middle panel: AgRP mRNA levels; upper right panel: NPY mRNA levels; lower left panel: Neuro-D mRNA levels; lower
right panel: COUP-TFII mRNA levels. Citrate control mice (%), STZ treated mice (&), STZ mice treated with insulin (grey square). Data are expressed as
mean 6 SEM. (n=6 mice/group). *P#0.05 **P#0.01 compared to citrate treated mice. 1 P#0.05 11P#0.01 compared to STZ treated mice.
doi:10.1371/journal.pone.0013464.g003
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expressing COUP-TFII (figure 5E). On the other hand, the
COUP-TFII neurons were all SF1 expressing neurons (figure 5E,
yellow fluorescence). Even so it was known that COUP-TFII
mRNA and SF1 mRNA were present in the VMH, this study
allowed the first identification of a subpopulation among the
VMH neurons expressing both the COUP-TFII and SF1 proteins.
The SF1 positive neurons have been characterized previously as
part of the circuitry controlling energy homeostasis and reproductive
behavior and are known to express the melanocortin receptor 4
(MC4-R) [22,23,24,25]. We confirmed the presence of this receptor
in the COUP-TFII positive neurons by co-localization experiments
and found that COUP-TFII neurons (figure 5F, red fluorescence) are
indeed MC4-R positive neurons (green fluorescence) (figure 5G),
Figure 4. COUP-TFII protein expression in adult mouse ventromedial hypothalamus. (A) Identification of the hypothalamic structures by
Kluver Barrera staining. Black square: Arcuate nucleus, red square: Ventromedial hypothalamic nucleus. (B–F) Immunostaining of brain sections from
adult mice using mouse monoclonal antibodies directed against COUP-TFII (PP-H7147-00, dilution 1:50). The secondary antibody is coupled with the
horse radish peroxydase and revealed with diaminobenzidine leading to a brown precipitate. The sections shown are from the same experiment with
the same exposure times. Magnification620. (C) Secondary antibody incubation control for COUP-TFII antibody specificity (D) Enlargement from the
VMH region, magnification 640. (E) Enlargement of the arcuate nucleus region (ARH), magnification 640. (F) Enlargement from the LHA region,
magnification640. These pictures are representative of 6 independent experiments. (G–J) Immunofluorescence staining of adult mice hypothalamic
cryostat sections, magnification620. (G) DAPI staining of the ARH-VMH region (blue fluorescence) (H) Identification of COUP-TFII positive neurons in
the VMH-ARH region of adult mice using the COUP-TFII monoclonal antibody (green fluorescence) (I) Identification of COUP-TFI positive neurons in
the VMH-ARH region of the hypothalamus using a COUP-TFI monoclonal antibody (red fluorescence) (J) Identification of COUP-TFI positive neurons in
the cortex region of the same cryostat section than (I) as a positive control for COUP-TFI antibody. Scale bars =100 mm.
doi:10.1371/journal.pone.0013464.g004
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COUP-TFII is expressed in the VMH in the SF1 positive neurons,
part of the melanocortin pathway.
COUP-TFII gene expression is modulated by the
melanocortin pathway in the GT1-7 hypothalamic cell
line
In the central nervous system, the fed state is characterized by
the production of a melanocyte-stimulating hormone (aMSH), the
hypothalamic POMC product which is synthesized by the neurons
of the ARH in response to insulin [26]. The aMSH receptors,
MC4-R and MC3-R, are present on numerous neurons from the
different hypothalamic nuclei, including the lateral hypothalamus
(LH) the paraventricular hypothalamus (PVN) and the VMH
where the COUP-TFII neurons are located (figure 5) [27,28].
COUP-TFII being expressed on neurons known to express the
MC4-R, we then checked whether an activation of this receptor
could contribute to COUP-TFII expression.
Figure 5. COUP-TFII protein co-localization studies with SF1 in the VMH. (A–G) Immunofluorescence staining of adult mice hypothalamic
cryostat sections. (A–E) The sections shown are from the same experiment with the same exposure time (A) Identification of SF1 positive cells in the
VMH by immunofluorescence using a SF1 polyclonal antibody (red fluorescence) (B) Identification of the COUP-TFII positive neurons in the VMH of
adult mice using a COUP-TFII monoclonal antibody (green fluorescence) (C) Secondary antibody alone control for SF1 antibody specificity (D)
Secondary antibody alone for COUP-TFII antibody specificity (E) Superimposed SF1 and COUP-TFII immunostaining. Magnification 640. (F–G) The
sections shown are from the same experiment and the same exposure time. (F) COUP-TFII immunostaining (red fluorescence) (G) Superimposed MC4-
R and COUP-TFII immunofluorescences. Magnification 6100. These pictures are representative of 4 independent experiments. Scale bars =10 mm.
doi:10.1371/journal.pone.0013464.g005
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agonist on hypothalamic COUP-TFII gene expression in a
hypothalamic mouse cell line, the GT1-7 cells, known to express
the insulin receptor, the COUP-TFII protein (data not shown) as
well as the MC4-R receptor [29].First, the cells were cultured for
18 hours with 100 nM insulin. Under these conditions, we
observed a strong repression of COUP-TFII mRNA levels by
insulin in cells directly exposed to insulin (figure 6A). On the other
hand, when the cells are cultured for 18 hoursin the presence of
increasing amounts of the MC4-R agonist, the melanotan II
(MTII), a aMSH analog, a concentration of 1 nM MTII is
sufficient to cause a significant increase of COUP-TFII mRNA
Figure 6. COUP-TFII gene expression in response to the MC4-R activation in GT1-7 cell line. GT1-7 cells were cultured for 18 hours in the
presence of either (A) insulin (100 nM) or increasing amount of (B) MTII or (C) DiBcAMP. Results are expressed as a fold increase over the value
obtained without MTII (A) or without DiBcAMP (B). (D) Transient transfection of a minimal COUP-TFII promoter in response to DiBcAMP. Data are
expressed as the mean 6 SEM. (n=4). *P#0.05 **P#0.01 when compared to cells cultured in the absence of MTII or DiBcAMP.
doi:10.1371/journal.pone.0013464.g006
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s-coupled receptor known to stimulate cAMP production following
agonist stimulation [30]. Indeed, we observed a dose dependant
accumulation of COUP-TFII mRNA in response to increasing
amount of the cAMP analog DiB-cAMP (figure 6C).
Previous studies from Soosaar et al. [31] had identified a
functional cAMP response element (CRE) binding site in the
promoter region of the mouse COUP-TFII gene. Following this
observation, we asked whether cAMP had a direct transcriptional
effect on the COUP-TFII gene promoter in an hypothalamic cell
line. To demonstrate the direct implication of cAMP in the control
of the COUP-TFII gene promoter, the GT1-7 cells were
transiently transfected with a reporter plasmid carrying the
luciferase gene controlled by the 328 bp 59 regulatory region.
We observed that the cAMP treatment induces in these neuronal
cells the -328/luc COUP-TFII construct (figure 6D).
All the experiments performed in this hypothalamic cell line
showed that COUP-TFII gene expression was increased by an
activation of the MC4-R signaling pathway. This led us to
hypothesize that, in vivo, the fed state induced COUP-TFII
expression through a local activation of the melanocortin pathway
in the VMH.
In vivo MC3/4-R activation induces COUP-TFII mRNA
levels in the hypothalamus
Therefore we tested the effects of intracerebroventricular (ICV)
injections of the MC3/4-R agonist MTII on COUP-TFII mRNA
levels in the hypothalamus. In our ICV experiments, mice were
subdivided into three groups: one group fed ad libitum on a regular
laboratory chow received an ICV injection of cerebrospinal fluid
(CSF). A second group fasted for 18 hours prior to the experiment
received an ICV injection of CSF, the last group fasted for
18 hours received a single MTII injection. Mice were sacrificed
4 hours after the injections.
As an activation of the hypothalamic MC3/4-Rs is known to
induce the expression of the brain derived neurotrophic factor
(BDNF) expression, a neurotrophin involved in energy homeosta-
sis [24,32,33], we analyzed its expression in our different groups of
mice. We observed higher BDNF mRNA levels in the fasting
MTII injected mice than in the control fasting mice (figure 7A).
Under these experimental conditions, a higher expression of
COUP-TFII mRNA in the fed mice than in the fasted mice was
observed, therefore the ICV per se did not disturb the previously
observed COUP-TFII mRNA regulation by the nutritional status
(figure 7C). On the other hand, the MTII-injected fasting mice
displayed significantly higher COUP-TFII mRNA levels than the
control fasting mice injected with CSF (figure 7C). Therefore, a
central activation of the melanocortin pathway in the fasting mice
induces COUP-TFII mRNA.
In fasting mice, when insulinemia and glycemia are low, an
activation of the melanocortin pathway leads to an activation of
COUP-TFII expression in the ventromedial hypothalamus.
A central activation of the melanocortin pathway
represses COUP-TFII mRNA levels in the liver and in the
pancreas
Previous data from our group had clearly shown that COUP-
TFII mRNA levels are inhibited in the liver and in the pancreas of
fed mice and by insulin in cultured hepatocytes and in a pancreatic
beta cell line [7]. As an activation of the melanocortin pathway in
the hypothalamus is known to affect gene expression through an
activation of the autonomous nervous system, leading to variations
in the phosphorylation state of the insulin signaling pathway in
peripheral organs [34][35]we asked whether a central activation of
the melanocortin pathway could also contribute to the regulation
of hepatic and pancreatic gene expression. In our experiments, a
central MTII injection failed to lower insulin levels in fasting mice,
as insulinemia was already physiologically at its lowest (figure 7D).
The ICV MTII injection leads to a slight but significant increase of
blood glucose concentrations (figure 7D) as previously described
[36]. First, we analyzed the expression of an hepatic gene known
to be modulated by a central induction of the melanocortin
pathway, the phosphenolpyruvate carboxykinase gene (PEPCK),
encoding an enzyme involved in hepatic gluconeogenesis. As
expected, the fed state was characterized by lower hepatic PEPCK
mRNA levels compared to the fasted state (figure 8A) and the
central injection of MTII in fasting mice was followed by a strong
inhibition of PEPCK mRNA expression, even lower than at the
fed state (figure 8A). When looking at the hepatic COUP-TFII
mRNA expression, it was higher in the control fasting mice
compared to the control fed mice as expected (figure 8B).
However, an ICV MTII injection in fasting mice strongly
inhibited COUP-TFII mRNA expression in the liver (figure 8B).
We also analyzed in these mouse models the pancreatic COUP-
TFII expression and observed a higher expression in the control
fasting mice than in the control fed mice as previously described
(figure 8C) [7]. On the other hand, the MTII injection in fasting
mice significantly inhibits COUP-TFII mRNA expression in the
pancreas (figure 8C). The MTII injection did not alter the neuro D
mRNA expression, a control gene whose expression is restricted to
the pancreatic beta cells (figure 8D).
In fasting mice, a direct activation of the melanocortin pathways
in the central nervous system reproduced the hypothalamic,
hepatic and pancreatic gene COUP-TFII expression profiles
observed in fed mice.
Discussion
The hypothalamus is a complex structure constituted of
anatomically distinct nuclei that work in a coordinate fashion to
regulate metabolic functions. Among them, the ventromedian
hypothalamus assumes several functions involved in sexual and
defensive behaviors. In addition, experiments with lesions of the
medial hypothalamus allowed the characterization of the ventro-
medial nucleus as the satiety center, its destruction resulting in
hyperphagia and obesity [37]. More recent studies have also
implicated neurons of the VMH as critical for courterregulatory
responses to hypoglycemia, since sympathetic response to
glucopenia are blocked by lesions of the VMH or by local infusion
of glucose in the VMH [38].
In this paper, we report a COUP-TFII gene expression
restricted to a subpopulation of neurons in the ventromedial
hypothalamus expressing the SF1 protein and described as
expressing the melanocortin receptor MC4-R [22,23,24,25]. We
then suggested that the fed state induction of COUP-TFII gene
expression in the VMH could be indirect, through an activation of
the melanocortin pathway by insulin. Indeed, even as the insulin
receptors are present in neurons from the different nuclei, the
highest expression is mainly described in the arcuate nuclei (ARH)
[39,40]. Moreover, binding assays with radiolabeled insulin had
shown a stronger binding in the ARH compared to the VMH.
These observations led to the idea that the prominent site of
insulin action are the neurons of the ARH over the other
hypothalamic nuclei [41]. Upon binding to its receptor in the
ARH, insulin triggers a repression of the AgRP and NPY gene
expression and an increase in POMC gene expression [26,42].
The POMC gene product is aMSH which is with AgRP part of
Neuronal COUP-TFII Regulation
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neuropeptides in the ARH are regarded as a key mechanism
mediating the insulin effect in the central nervous system. In
keeping with this mechanism, we observed that in our nutritional
and hormonal, eGHI and STZ mouse models, variations of
circulating plasma insulin are closely associated with variation of
the hypothalamic COUP-TFII mRNA levels, paralleling the
modulation of POMC gene expression and therefore of the
melanocortin receptor agonist (aMSH) production. Our experi-
ments on a hypothalamic cell line with insulin showed that this
hormone was able to repress COUP-TFII mRNA expression
when applied directly on the cells expressing COUP-TFII as it was
observed on a pancreatic beta cell line or on cultured hepatocytes
[7]. In vivo, the observed induction of COUP-TFII gene expression
by the fed state could be therefore mediated indirectly by insulin
through the conjunction of decreasing amount of AgRP and
increasing amount of POMC leading downstream to an activation
of the MC3/4-R.
MC4-R and MC3-R have been shown to be widely distributed
throughout different hypothalamic regions, with a higher expression
in the ARH, the VMH, the dorso medial hypothalamus, the
paraventricular nucleus and the median eminence [27,28]. There-
foreinour in vivo experimentswith a central ventricular injection of a
MC3/4-R agonist, the MTII, a complex network of neurons
Figure 7. Regulation of hypothalamic COUP-TFII mRNA levels in vivo by activation of the melanocortin pathway. (A-C) RT-qPCR
analysis of mRNA levels from hypothalamus of ad libitum fed mice receiving a ICV injection of CSF (%), or 18 h fasting mice receiving a ICV injection
of CSF (grey bar), or 18 h fasting mice with a ICV injection of MTII (&). (A) BDNF mRNA levels (B) Neuro D mRNA levels (C) COUP-TFII mRNA levels.
Data are expressed as mean 6 SEM (n=5) *P#0.05 **P #0.01 when compared to control fed mice receiving a CSF injection. 1 P#0.05 when
compared to control fasting mice receiving a CSF injection. (D) Glucose and plasma insulin concentrations from the different mouse models.
doi:10.1371/journal.pone.0013464.g007
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amus. Using a hypothalamic cell line expressing the MC4-R
receptor, we have shown that its direct activation induces COUP-
TFII mRNA levels in these cells, so part of the MTII effect on
COUP-TFII gene expression in vivo is mediated through a direct
activation of the melanocortin receptors expressed on the VMH
neurons. MC3/4-R belongs to the family of G protein-coupled
seven-transmembrane-domain receptors and the binding of its
agonist induces an increased cAMP production [30]. A COUP-TFII
gene promoter analysis had identified cAMP response element
localized in the first 300 bp from the transcription start site [31]. In
our hypothalamic cell line it did drive also the cAMP dependant
activation of the COUP-TFII gene. So in vivo, an activation of the
MC3/4-R could affect COUP-TFII gene expression directly
through a transcriptional mechanism regardless of the peripheral
effect of MTII on the other nuclei.
Our previous studies had shown that insulin was down-
regulating COUP-TFII gene expression in liver and pancreas. In
regards to COUP-TFII functions in those tissues, i.e controlling the
glucose dependant insulin secretion by the pancreatic beta cells
and gluconeogenesis by the hepatocytes, this coordinated down-
regulation is therefore contributing to glucose homeostasis [7]. In
the hypothalamus, we observed an up regulation of its expression
in fed mice, i.e. when peripheral insulinemia is at his highest. This
apparent opposite effect of insulin on COUP-TFII gene expression
is reminiscent of the overall observation regarding peripheral vs
central insulin effects on energy homeostasis. In peripheral tissues,
insulin is rightly considered as the anabolic hormone: insulin
injections induce hypoglycemia with a temporary increase in food
intake as a consequence and it will promote fuel storage in
peripheral organs, mainly in liver and adipose tissues. On the
other hand, the central effect of insulin on the hypothalamus is
Figure 8. Regulation of hepatic and pancreatic COUP-TFII mRNA levels by activation of the melanocortin pathway. (A–D) RT-qPCR
analysis of mRNA from livers (A–B) or pancreas (C–D) of ad libitum fed mice receiving a ICV injection of CSF (%), or 18 h fasting mice receiving a ICV
injection of CSF (grey bar), or 18 h fasting mice with a ICV injection of MTII (&). (A) Hepatic PEPCK mRNA levels (B) Hepatic COUP-TFII mRNA levels.
(C) Pancreatic COUP-TFII mRNA levels (D) Pancreatic Neuro D mRNA levels. Data are expressed as mean 6 SEM (n=5) *P#0.05 when compared to
control fed mice receiving a CSF injection. 1 P#0.05 when compared to control fasting mice receiving a CSF injection.
doi:10.1371/journal.pone.0013464.g008
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One other striking evidence of differential regulation between
hypothalamus and peripheral tissues is the fuel gauge AMPK,
whose activity is decreased by leptin in the hypothalamus but
increased in skeletal muscle leading to a coordinate control of fuel
expenditure and food intake [43]. More recently, a protein with a
crucial function in the maintenance of glucose homeostasis, the
cyclic AMP-response element binding protein (CREB) regulated
protein co-activator 2 (CRTC2) has been described as displaying a
differential regulation by the nutritional status in liver and
hypothalamus [44]. At the fed state CTRC2 is cytoplasmic in
hepatocytes and nuclear in hypothalamic neurons where it will
differentially regulate hypothalamic and hepatic CRE gene
expression [44]. Taken all together these different observations
on the peripheral vs central effect of the nutritional status are
logical if we consider the ventromedial hypothalamus as part of the
feedback loop in charge not only of the maintenance of the energy
stores but also of euglycemia, a sort of check point balancing the
peripheral effects of the nutritional status. Having an opposite
regulation of COUP-TFII expression between these different
organs could then participate in this global homeostasis.
In this paper, we described the unique and restricted
localization of COUP-TFII expression to a subpopulation of
VMH neurons expressing the transcription factor SF1. Actually,
these VMH neurons expressing COUP-TFII are well character-
ized for their involvement in controlling energy homeostasis.
Indeed, SF1 gene knockout mice displayed an abnormal VMH
development leading to obesity [23]. This demonstrates, outside of
SF1 function in neuronal development, the involvement of such
neurons in the control of food intake and fuel expenditure [23].
These neurons are known to control food intake through the
production of BDNF, a neurotrophin whose expression in the
VMH is increased in response to the activation of MC3/4-R
[24,32,33].
These COUP-TFII positive neurons also express the MC4-R.
Since mutations in the human MC4-R or deletion in mouse
models have been associated with obesity, this receptor has
received much attention as a potential drug target to treat this
pathology [45,46,47,48]. Interestingly, most of this attention has
been brought on its involvement in the control of food intake but
it has been clearly shown that the melanocortin pathway play a
global role in energy homeostasis. It stimulates oxygen con-
sumption, inhibits basal insulin release and glucose tolerance,
and this impaired insulin intolerance occurs prior to the onset of
hyperphagia and obesity [49]. These data suggest that the central
melanocortin system regulates not only energy intake, but also
energy partitioning, as indicated by effects on insulin release and
peripheral insulin responsiveness. As much as we know of the
natural agonist and antagonist of this receptor, aMSH and
AgRP, there is a lack of identified downstream effectors of this
receptor. Indeed, so far, very few targets have been clearly
identified. In the VMH and the dorsomedial hypothalamus, the
BDNF gene expression is clearly modulated by MC4-R
activation and several lines of evidence have also identified the
Single Minded 1 as a downstream target of MC4-R in the
paraventricullar hypothalamus [50,51]. Identifying downstream
target genes, such as COUP-TFII, could be the first step in
understanding the molecular mechanisms underlying the mela-
nocortin-mediated regulation of energy homeostasis. Undoubt-
edly, mice models with a specific invalidation of its expression
restricted to the VMH neurons will be an invaluable tool in
deciphering the proper implication of COUP-TFII as a central
component of the hypothalamic integration of energy status and
energy balance regulation.
In conclusion, COUP-TFII expression is regulated in the VMH
by insulin levels aside of circulating glucose and this suggests a
possible role as a modulator of the counter regulation engaged by
the VMH in response to neuroglucopenia or hypoglycemia.
Materials and Methods
Animals
C57bl/6J male mice (Charles River, France) were used in this
study. They were adapted to the facility environment for 2 weeks
prior to the different studies. Animals were housed in colony cages
with a 12-h light/12-h dark cycle in a temperature-controlled
environment and fed ad libitum with a standard laboratory chow
diet: composition 65% carbohydrate, 11% lipids, and 24%
proteins (SAFE, France). All animal protocols were undertaken
according to the Guidelines for Care and Use of Experimental
Animals. Animal experimentation permit number 75-739 (Certi-
ficat d’autorisation d’expe ´rimenter sur animaux verte ´bre ´s num-
ber 75-739) given by the veterinarian services board (Dr.
Claudine Crochet, D.V.M). Animal care facility agreement
number A-75-14-02.
Streptozotocin injections
Ten weeks old C57bl/6J male mice were used in these
experiments. Streptozotocin (STZ) is dissolved extemporaneously
in citrate buffer at pH 4.5 and administered daily at 180 mg/kg
body weight (Sigma, St. Louis, MO, USA) for two days. Control
mice received two citrate buffer injections. Food and water were
provided ad libitum during the remaining 7 days of the experiment.
After the injection, mice were checked daily for plasma glucose
concentration via the tail vein with a blood glucometer (Roche
diagnostic, Meylan, France). A subgroup of STZ treated mice
received an intraperitoneal injection of insulin (1.5 U/kg)
(Actrapid, Novo Nordisk) 2 hours prior to the sacrifice.
Euglycemic-hyperinsulinemic (eGHI) clamped mice
Ten weeks old C57bl/6J male mice were used in the eGHI
experiments. Mice were catheterized at least 2 days before the
experiment. They were anesthetized with a mixture of ketamine
(100 mg/kg of body weight) and xylazine (10 mg/kg of body
weight). The right jugular vein was catheterized with a silastic
catheter for infusion. The free end of the catheter was tunneled
under the skin to the back of the neck and passed through a piece
of Tygon tubing, glued together, and secured to the skin [7]. Lines
were flushed daily with 50 ml of 0.9% NaCl containing 5 mg/ml
ampicillin and 20 IU/ml heparin. After surgery, animals were
housed individually and weighed daily. After a 5 h fast on the day
of experiment, awaken animals were placed unrestrained into their
cage during the perfusion. Two groups of mice were studied: a
saline-infused (control group) and glucose infused/insulin-infused
(euglycemic-hyperinsulinemic [eGHI]) group. In eGHI mice,
hyperinsulinemia was induced by a 3-h insulin infusion at a
constant rate of 0.6 IU/kg/h (Actrapid; Novo-Nordisk) and
euglycemia was maintained by a simultaneous glucose infusion
at a flow rate adjusted to the basal glycemia, around 100 mg/dl.
Blood glucose levels were determined from tail blood samples at
time zero and then every 15 min. Steady state was reached when
glucose measurements were constant for at least 20 min at a fixed
glucose infusion rate and was achieved within 30 to 45 min.
Plasma insulin concentrations were measured with a radioimmu-
noassay kit (Insik-5 kit; Diasorin). At the end of the infusion, mice
were killed by pentobarbital injection, and the hypothalamus
frozen in liquid nitrogen and kept at 280uC until analysis.
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The mouse GT1-7 hypothalamic cell line [52] was used
between passage 31 and 37. The cells were grown in 5% CO2-
95% air at 37uC in Dubelco modified Eagle medium (DMEM)
containing Glutamax 1x supplemented with 10% (vol/vol) of heat
inactivated fetal calf serum and 100 U/ml penicillin-streptomycin.
For melanotan II (MTII) (Phoenix pharmaceuticals, Burlingame,
CA, USA) or Dibutyryl-cAMP (DiBcAMP) (Sigma, St. Louis, MO,
USA) dose response experiments, cells were seeded in 12 well
plates at a density of 150,000 cells/well. Twenty four hours after
plating, cells were cultured in presence of MTII or DiBcAMP for
16 h prior to the RNA extraction.
Plasmids, transfection and reporter gene assay
The reporter plasmid -328 (Apa I) to +873 (BglII) relative to the
transcription initiation site was described in Perilhou et al. (-328/
luc) [53]. Cells were plated at density 150,000/well in GT1-7
medium. Transient transfections were carried out with Lipofecta-
mine 2000 reagent (Invitrogen, Cergy, France), 800 ng of reporter
plasmid and 100 ng of internal control. The following day the cells
were treated with DiBcAMP for 6 hours and cell extracts were
assayed for reporter enzyme activities, using the dual luciferase kit
(Promega, Charbonnieres, France) as described previously [53].
Isolation of total mRNA and quantitative analysis by real
time RT-PCR
Total RNAs were extracted and purified from hypothalamus,
cultured GT1-7 cells and liver using the RNA-Plus reagent (Q-
BIOgene, Montreuil, France) according to the manufacturer
instructions. For RNA extraction from flash frozen pancreas, the
tissues were powdered in liquid nitrogen using a steel mortar and
pestle. A frozen minute amount of powdered pancreas was then
immediately homogenized in a chaotropic buffer and RNA were
extracted using the RNAeasy kit (Qiagen, Courtaboeuf, France)
according to the manufacturer instructions. Reverse transcription
was performed with 1 mg of total RNA using the Superscript II
reverse transcriptase (Invitrogen, Cergy, France). Real time PCR
was performed using 6.25 ng of reverse-transcribed RNA
subsequently mixed with Fast Start DNA Master Sybr Green
(Roche, Meylan, France), 2 mM MgCl2 and various set of gene
specific forward and reverse primers in a final volume of 10 ml.
The relative amount of each mRNA was calculated using the 2
nd
derivative Ct method. Quantification was obtained after normal-
ization to cyclophilin mRNA and inter-assay variations using an
RT-calibrator [54].
Forward and reverse primers used for the specific amplification
of mouse cDNA fragments were: COUP-TFII: 59-CGC TCC
TTG CCG CTG CT-39 and 59-AAG AGC TTT CCG AAC
CGT GTT-39,C y c l o p h i l i n :5 9-TTG CCA TTC CTG GAC
CCA AA-39 and 59-ATG GCA CTG GTG GCA AGT CC-39
Neuro D1: 59-GCC CAG CTT AAT GCC ATC TTT-39 and 59-
CAA AAG GGCTGC CTT CTG TAA-39 Brain-derived
neurotrophic factor (BDNF): 59-CAG GGG CAT AGA CAA
AAG -39and 59-CTT CCC CTT TTA ATG GTC-39,P r o -
opiomelanocortin (POMC): 59-ATG CCG AGA TTC TGC
TAC AGT CG-39and 59- T CA T CT C CG T TG C CA G GA A A
CAC -39, Agouti related protein (AgRP): 59-TT TGG GAG AGC
G T GT A AC T GA A - 3 9and 59-CT CCA TAT CGT GGT CTG
AAA CTG-39, Phosphoenolpyruvate carboxykinase (PEPCK): 59
GTG CTG GAG TGG ATG TTC GG 39and 59 CTG GCT
GAT TCT CTG TTT CAG G 39, Neuropeptide Y(NPY): 59
TTC TGT GCT TTC CTT CAT 39 and 59 GTG TTT GGG
CAT TCT G 39.
Western blot analysis and ECL detection
Nuclear extracts were prepared from fresh tissues as described
previously by Bossard et al. [55]. Western blot were done using
30 mg of nuclear extracts and according to Perilhou et al. [7].
Immunohistological studies
Two-month-old C57Bl/6J male mice were decapitated and
their brains were removed, frozen at 235uC for 2 minutes in
isopentane and stored at 280uC. Frozen brains were mounted and
placed in a cryostat and 7 mm sections were cut in the coronal
plane. One section out of 20 was stained by the Kluver Berrera
method which by staining the myelin in a bluish hue and the cells
structures in violet allows the visualization of the different brain
structures [56]. For COUP-TF immunostaining, sections were
fixed in 1% paraformaldehyde for 20 min at 4uC then
permeabilized with 0.1% triton in 1X Phosphate buffer saline
(PBS) for 10 min at room temperature. The sections were
incubated with a mouse IgG blocking agent (Mouse-on-Mouse,
Vector, USA), then incubated overnight at 4uC with mouse
monoclonal primary antibodies: COUP-TFII/NR2F2 (PP-
H7147-00, dilution 1:50) or the COUP-TFI/NR2F1 (PP-
H8132-00, dilution 1:100). The following day, the sections were
washed and revealed using an anti-mouse antibody coupled with a
peroxidase labeling enhancement system (Envision DAB-HRP,
Dakocytomation). On the same slide, a serial section was treated
without the primary antibody as a control for secondary antibody
specificity. For immunofluorescence double staining, the slides
were incubated overnight at 4uC with mixed primary antibodies
directed against SF1 (rabbit anti SF1 polyclonal antibody,
Ab3436, AbCam, dilution 1:100) and against COUP-TFII (PP-
H7147-00, dilution 1:50), or against COUP-TFII and MC4-R
(goat anti MC4-R polyclonal antibody, R-19, Santa Cruz, dilution
1:100), then with mixed secondary antibodies: FITC conjugated
anti-mouse and Texas Red conjugated anti rabbit for SF1/
COUP-TFII double staining or Alexa 568 conjugated anti-mouse
and Alexa 488 conjugated anti-goat for MC4-R/COUP-TFII
double staining, at room temperature for 1 h. The slides were
mounted in DAPI (4-6-diamidino-2-phenylindole) containing
Vectashield (Vector Laboratories, Philadelphia, PA, USA) for
the nuclei counterstaining and stored at 4uC until observation.
The different specificity controls were done on the same slides: a
section was incubated with only one of the primary antibody then
incubated with the mixed secondary antibodies. A serial section is
also treated without any primary antibody, as a control for the
secondary antibodies specificity.
Intracerebroventricular (ICV) injection
Twelve weeks old C57bl/6J male mice were anaesthetized with
isofluran (2.5%). After the initial anaesthesia, they were connected
at the snout to a device providing isofluran at 1.5% for the surgery
duration. As soon the animals were anaesthetized, they received
an injection of xylazine and xylocaine (10 mg/kg of body weight).
A chronic guide cannula (26 ga, Plastic One Products, Roanoke,
VA) was implanted into the right lateral brain ventricle to
coordinates X=21 mm, Y=20.4 mm, Z=22.5 mm from the
Bregma using a Kopf stereotaxic instrument (David Kopf
Instruments, Tujunga, CA, USA). The 26 stainless steel gauge
guide cannula (Plastic One Products, Roanoke, VA, USA) was
maintained in place by dental cement anchored to one stainless
steel jewelry screw fixed to the skull. A 28 gauge dummy cannula
was inserted to prevent clogging of the guide cannula. After the
surgery, the animals were housed individually with direct bedding
for 10 days during which they were handled (about 5 min daily)
and accustomed to the placement of the ICV injector. Paracet-
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weight was accessed daily. For the ICV injection, an injector was
connected to a catheter containing the MC4-R agonist MTII or its
vehicle (artificial cerebrospinal fluid (CSF) (Alzet, Cupertino CA,
USA)) and inserted into the guide cannula in the non restrained
conscious mice. This catheter was connected to a Hamilton
syringe powered by a mini-pump KDS310 (KD Scientific,
Holliston,MA, USA).
A small air bubble (1 ml) was drawn at the distal end of the
catheter to separate the injected solution from the water and for
visual inspection of injections which were performed slowly over a
50–60 sec period. The volume was 1 ml in a single injection at the
rate of 1 ml/min. Only mice who recovered their normal body
weight one week after the surgery were included in this study.
Statistical analysis
Quantitative results are expressed as means 6 standard errors
of the means (SEM). Statistical analyses are carried out using the
Mann-Whitney test, a nonparametric statistical program appro-
priate for sample number less than 10. Null hypotheses are
rejected at P values of #0.05.
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